Targeting Cardiac Fibrosis in Diabetic Heart Failure: The Role of the EZH2, AMPK, and PPAR-γ Pathways (Diabetes Metab J 2024;48:716-29)
Jooyeop Lee, Joon Ho Moon · 2024
Read Targeting Cardiac Fibrosis in Diabetic Heart Failure: The Role of the EZH2, AMPK, and PPAR-γ Pathways (Diabetes Metab J 2024;48:716-29) by Jooyeop Lee, Joon Ho Moon (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11621649.txt.
Description
Jooyeop Lee and Joon Ho Moon write a commentary in two thousand twenty-four on how heart scarring develops in diabetic heart failure. Heart disease is the top cause of death worldwide, and diabetes raises the risk sharply. Scarring of the heart muscle, called fibrosis, is one path by which diabetes weakens the heart.
The commentary discusses a study that traced a chain of four molecular switches in rat and mouse models. High sugar blocked the first switch, which freed a second to silence a protective third factor. That silencing let scarring proteins build up in the heart. Drugs that act on parts of the chain are already known in diabetes care. The authors argue the chain offers fresh targets for treatment. New drugs with distinct actions could add to current protective options.
Catalog record
| CREATOR | Jooyeop Lee, Joon Ho Moon |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 6 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |